Stock A310210 VORONOI, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Voronoi, Inc.

Equities

A310210

KR7310210000

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-30 pm EDT 		5-day change 1st Jan Change
41,500 KRW -0.36% Intraday chart for Voronoi, Inc. +13.39% -23.15%
2023 Voronoi, Inc.(KOSDAQ:A310210) added to S&P Global BMI Index CI
2023 Voronoi to Raise 45 Billion Won From Shares Issuance; Shares Jump 9% MT

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Voronoi, Inc.

Voronoi, Inc.(KOSDAQ:A310210) added to S&P Global BMI Index CI
Voronoi to Raise 45 Billion Won From Shares Issuance; Shares Jump 9% MT
Voronoi, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Voronoi Signs $482 Million Deal to Develop Oral Kinase Inhibitor MT
METiS Therapeutics Announces Pan-RAF Inhibitor License Agreement with Voronoi CI
Voronoi, Inc. has completed an IPO in the amount of KRW 52 billion. CI
Voronoi, Inc. has filed an IPO in the amount of KRW 59.8 billion. CI
Voronoi, Inc. has withdrawn its IPO in the amount of KRW 130 billion. CI
Voronoi, Inc. has filed an IPO. CI
ORIC Pharmaceuticals, Inc. Enters into an Exclusive License Agreement with Voronoi, Inc CI

Chart Voronoi, Inc.

Chart Voronoi, Inc.
More charts

Company Profile

Voronoi Inc is a Korea-based company principally engaged in the research and development of new drug candidates. The Company is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The Company is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
Sector
Biotechnology & Medical Research
Calendar
2024-06-02 - Investor Meeting - Day - 1
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
41,500 KRW
Average target price
85,000 KRW
Spread / Average Target
+104.82%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
VORONOI, INC. Stock Voronoi, Inc.
-23.15% 519M
MODERNA, INC. Stock Moderna, Inc.
+43.36% 54.64B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.31% 39.92B
LONZA GROUP AG Stock Lonza Group AG
+37.52% 38.82B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+14.75% 26.86B
CELLTRION, INC. Stock Celltrion, Inc.
-12.56% 26.22B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.45% 18.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.12% 12.21B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.04% 12.16B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.04% 11.94B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A310210 Stock
  4. News Voronoi, Inc.
  5. Voronoi Signs $482 Million Deal to Develop Oral Kinase Inhibitor